Internal Medicine, Medical Oncology · Houston, TX
NPI
1760588693
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
318 services
Medicare patients, 2024
125
Average age 71
Drug cost, 2024
$4.2M
473 prescriptions
Company payments, 2025
$9,660
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nizar M Tannir was code 99215 (office e&m - established), 186 times for 85 patients. In total Nizar M Tannir billed 318 services in 6 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 186 | 85 | $113.16 | $21K |
| 99214 Office E&M - Established | Facility | 88 | 54 | $76.96 | $6,772 |
| 99205 Office E&M - New | Facility | 34 | 34 | $141.61 | $4,815 |
By year: 2022 $38K for 366 services; 2023 $31K for 302 services; 2024 $34K for 318 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nizar M Tannir prescribed most often to Medicare patients was Lenvima (Lenvatinib Mesylate), with 78 prescriptions and refills. In total Nizar M Tannir wrote 473 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lenvima Lenvatinib Mesylate | 78 | 78 | 14 | $1.8M |
| Everolimus Generic | 69 | 69 | 12 | $222K |
| Cabometyx Cabozantinib S-Malate | 49 | 49 | 14 | $1.2M |
| Nifedipine Er Nifedipine | 35 | 39 | Under 11 | $630 |
| Welireg Belzutifan | 24 | 24 | Under 11 | $693K |
| Levothyroxine Sodium Generic | 22 | 38 | Under 11 | $148 |
| Carvedilol Generic | 19 | 33 | Under 11 | $76.39 |
| Eliquis Apixaban | 12 | 18 | Under 11 | $9,937 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 12 | 12 | Under 11 | $269 |
| Mirtazapine Generic | 11 | 11 | Under 11 | $54.4 |
Brand drugs: 199 claims; generic drugs: 274 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nizar M Tannir $9,660 ($9,660 in general payments such as food, travel and fees) from 13 companies. The largest payer was Eisai Inc. with $2,968.
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. 4523.T | 3 | $2,968 |
| Eisai Co., Ltd. 4523.T | 1 | $2,910 |
| Merck Sharp & Dohme LLC MRK | 3 | $1,802 |
| Exelixis Inc. EXEL | 79 | $1,185 |
| Pfizer Inc. PFE | 2 | $299 |
| Aveo Pharmaceuticals, Inc. | 2 | $205 |
| Telix Pharmaceuticals TLX | 1 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $87.63 |
| pharmaand GmbH | 1 | $26.94 |
| Tolmar, Inc. | 1 | $26.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.